84 related articles for article (PubMed ID: 35879396)
21. GNAS mutation as an alternative mechanism of activation of the Wnt/β-catenin signaling pathway in gastric adenocarcinoma of the fundic gland type.
Nomura R; Saito T; Mitomi H; Hidaka Y; Lee SY; Watanabe S; Yao T
Hum Pathol; 2014 Dec; 45(12):2488-96. PubMed ID: 25288233
[TBL] [Abstract][Full Text] [Related]
22. Gsα Controls Cortical Bone Quality by Regulating Osteoclast Differentiation via cAMP/PKA and β-Catenin Pathways.
Ramaswamy G; Kim H; Zhang D; Lounev V; Wu JY; Choi Y; Kaplan FS; Pignolo RJ; Shore EM
Sci Rep; 2017 Mar; 7():45140. PubMed ID: 28338087
[TBL] [Abstract][Full Text] [Related]
23. WNT as a Driver and Dependency in Cancer.
Parsons MJ; Tammela T; Dow LE
Cancer Discov; 2021 Oct; 11(10):2413-2429. PubMed ID: 34518209
[TBL] [Abstract][Full Text] [Related]
24. Targeting primary and metastatic uveal melanoma with a G protein inhibitor.
Onken MD; Makepeace CM; Kaltenbronn KM; Choi J; Hernandez-Aya L; Weilbaecher KN; Piggott KD; Rao PK; Yuede CM; Dixon AJ; Osei-Owusu P; Cooper JA; Blumer KJ
J Biol Chem; 2021; 296():100403. PubMed ID: 33577798
[TBL] [Abstract][Full Text] [Related]
25. Complex roles of cAMP-PKA-CREB signaling in cancer.
Zhang H; Kong Q; Wang J; Jiang Y; Hua H
Exp Hematol Oncol; 2020 Nov; 9(1):32. PubMed ID: 33292604
[TBL] [Abstract][Full Text] [Related]
26. G Protein-Coupled receptors and heterotrimeric G proteins as cancer drivers.
Arang N; Gutkind JS
FEBS Lett; 2020 Dec; 594(24):4201-4232. PubMed ID: 33270228
[TBL] [Abstract][Full Text] [Related]
27. Methylation changes at the
Faias S; Duarte M; Pereira L; Chaves P; Cravo M; Dias Pereira A; Albuquerque C
World J Gastrointest Oncol; 2020 Sep; 12(9):1056-1064. PubMed ID: 33005298
[TBL] [Abstract][Full Text] [Related]
28. Integrated clinico-molecular profiling of appendiceal adenocarcinoma reveals a unique grade-driven entity distinct from colorectal cancer.
Raghav K; Shen JP; Jácome AA; Guerra JL; Scally CP; Taggart MW; Foo WC; Matamoros A; Shaw KR; Fournier K; Overman MJ; Eng C
Br J Cancer; 2020 Oct; 123(8):1262-1270. PubMed ID: 32733093
[TBL] [Abstract][Full Text] [Related]
29. The biological basis and function of GNAS mutation in pseudomyxoma peritonei: a review.
Lin YL; Ma R; Li Y
J Cancer Res Clin Oncol; 2020 Sep; 146(9):2179-2188. PubMed ID: 32700107
[TBL] [Abstract][Full Text] [Related]
30. Unbiased Proteomic Profiling Uncovers a Targetable GNAS/PKA/PP2A Axis in Small Cell Lung Cancer Stem Cells.
Coles GL; Cristea S; Webber JT; Levin RS; Moss SM; He A; Sangodkar J; Hwang YC; Arand J; Drainas AP; Mooney NA; Demeter J; Spradlin JN; Mauch B; Le V; Shue YT; Ko JH; Lee MC; Kong C; Nomura DK; Ohlmeyer M; Swaney DL; Krogan NJ; Jackson PK; Narla G; Gordan JD; Shokat KM; Sage J
Cancer Cell; 2020 Jul; 38(1):129-143.e7. PubMed ID: 32531271
[TBL] [Abstract][Full Text] [Related]
31. Comprehensive tumor profiling reveals unique molecular differences between peritoneal metastases and primary colorectal adenocarcinoma.
Stein MK; Williard FW; Xiu J; Tsao MW; Martin MG; Deschner BW; Dickson PV; Glazer ES; Yakoub D; Shibata D; Grothey AF; Philip PA; Hwang JJ; Shields AF; Marshall JL; Korn WM; Lenz HJ; Deneve JL
J Surg Oncol; 2020 Jun; 121(8):1320-1328. PubMed ID: 32166754
[TBL] [Abstract][Full Text] [Related]
32. Wnt signaling in cancer: therapeutic targeting of Wnt signaling beyond β-catenin and the destruction complex.
Jung YS; Park JI
Exp Mol Med; 2020 Feb; 52(2):183-191. PubMed ID: 32037398
[TBL] [Abstract][Full Text] [Related]
33. Typing tumors using pathways selected by somatic evolution.
Wang S; Ma J; Zhang W; Shen JP; Huang J; Peng J; Ideker T
Nat Commun; 2018 Oct; 9(1):4159. PubMed ID: 30297789
[TBL] [Abstract][Full Text] [Related]
34. Prognostic Implications of Mucinous Differentiation in Metastatic Colorectal Carcinoma Can Be Explained by Distinct Molecular and Clinicopathologic Characteristics.
Khan M; Loree JM; Advani SM; Ning J; Li W; Pereira AAL; Lam M; Raghav K; Morris VK; Broaddus R; Maru D; Overman MJ; Kopetz S
Clin Colorectal Cancer; 2018 Dec; 17(4):e699-e709. PubMed ID: 30205948
[TBL] [Abstract][Full Text] [Related]
35. GNAS
Ideno N; Yamaguchi H; Ghosh B; Gupta S; Okumura T; Steffen DJ; Fisher CG; Wood LD; Singhi AD; Nakamura M; Gutkind JS; Maitra A
Gastroenterology; 2018 Nov; 155(5):1593-1607.e12. PubMed ID: 30142336
[TBL] [Abstract][Full Text] [Related]
36. Mutant GNAS drives pancreatic tumourigenesis by inducing PKA-mediated SIK suppression and reprogramming lipid metabolism.
Patra KC; Kato Y; Mizukami Y; Widholz S; Boukhali M; Revenco I; Grossman EA; Ji F; Sadreyev RI; Liss AS; Screaton RA; Sakamoto K; Ryan DP; Mino-Kenudson M; Castillo CF; Nomura DK; Haas W; Bardeesy N
Nat Cell Biol; 2018 Jul; 20(7):811-822. PubMed ID: 29941929
[TBL] [Abstract][Full Text] [Related]
37. Disease-Causing Mutations in the G Protein Gαs Subvert the Roles of GDP and GTP.
Hu Q; Shokat KM
Cell; 2018 May; 173(5):1254-1264.e11. PubMed ID: 29628140
[TBL] [Abstract][Full Text] [Related]
38. The curious case of Gαs gain-of-function in neoplasia.
Innamorati G; Wilkie TM; Kantheti HS; Valenti MT; Dalle Carbonare L; Giacomello L; Parenti M; Melisi D; Bassi C
BMC Cancer; 2018 Mar; 18(1):293. PubMed ID: 29544460
[TBL] [Abstract][Full Text] [Related]
39. Induced
Khan SK; Yadav PS; Elliott G; Hu DZ; Xu R; Yang Y
Proc Natl Acad Sci U S A; 2018 Jan; 115(3):E418-E427. PubMed ID: 29158412
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
